Ortega-Torres Angelica, Sánchez-Díaz Germán, Villaverde-Hueso Ana, Posada de la Paz Manuel, Alonso-Ferreira Verónica
Servicio de Medicina Preventiva, Hospital Universitario Infanta Sofía, Madrid, España.
Instituto de Investigación de Enfermedades Raras, Instituto de Salud Carlos III, Madrid, España; CIBER de Enfermedades Raras (CIBERER), España; Departamento de Geología, Geografía y Medioambiente, Universidad de Alcalá de Henares, Madrid, España.
Gac Sanit. 2020 Jan-Feb;34(1):37-43. doi: 10.1016/j.gaceta.2018.08.004. Epub 2018 Dec 29.
To identify the mortality directly attributed to hereditary haemorrhagic telangiectasia (HHT) in Spain, and to analyze its time trends and geographic variability.
Population-based deaths due to HHT were selected from the Spanish National Statistics Institute: codes 448.0 (ICD-9, 1981-1998) and I78.0 (ICD-10, 1999-2016) as the basic cause of death. Specific and age-adjusted mortality rates were calculated by sex, as well as standardized mortality ratios (SMR) by province and district, and smoothed SMR.
We identified 327 deaths attributed to HHT (49.5% women), with the highest mortality at 80-84 years in men (0.220 per 100,000 inhabitants) and at 75-79 years in women (0.147 per 100,000 inhabitants). Age-adjusted mortality rates did not show any significant time trend between 1981 and 2016 in Spain. The provinces of Navarra, Cantabria, Guipúzcoa, Pontevedra and Las Palmas had higher than expected mortality, as well as the regions of Monte Sur (Ciudad Real) and Ripollès (Girona).
This study has identified some regions with higher risk of death due to HHT in Spain. It is unknown whether these differences are associated with the distribution of types HHT1 and HHT2, and further studies will be necessary to know the determinants of this geographical variability. These findings are useful to complement the information provided by other studies and registries, and for health planning.
确定西班牙直接归因于遗传性出血性毛细血管扩张症(HHT)的死亡率,并分析其时间趋势和地理变异性。
从西班牙国家统计局选取以HHT为根本死因的基于人群的死亡数据:国际疾病分类第九版(ICD - 9,1981 - 1998年)编码448.0和国际疾病分类第十版(ICD - 10,1999 - 2016年)编码I78.0。按性别计算特定死亡率和年龄调整死亡率,以及按省份和地区计算标准化死亡率(SMR)和平滑SMR。
我们确定了327例归因于HHT的死亡病例(49.5%为女性),男性在80 - 84岁时死亡率最高(每10万居民0.220),女性在75 - 79岁时死亡率最高(每10万居民0.147)。1981年至2016年期间,西班牙年龄调整死亡率未显示出任何显著的时间趋势。纳瓦拉、坎塔布里亚、吉普斯夸、蓬特韦德拉和拉斯帕尔马斯等省份以及南蒙特(雷阿尔城)和里波列斯(赫罗纳)地区的死亡率高于预期。
本研究确定了西班牙一些因HHT导致死亡风险较高的地区。尚不清楚这些差异是否与HHT1型和HHT2型的分布有关,需要进一步研究以了解这种地理变异性的决定因素。这些发现有助于补充其他研究和登记处提供的信息,并用于卫生规划。